BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28633667)

  • 1. HPV and cofactors for invasive cervical cancer in Morocco: a multicentre case-control study.
    Berraho M; Amarti-Riffi A; El-Mzibri M; Bezad R; Benjaafar N; Benideer A; Matar N; Qmichou Z; Abda N; Attaleb M; Znati K; El Fatemi H; Bendahhou K; Obtel M; Filali Adib A; Mathoulin-Pelissier S; Nejjari C
    BMC Cancer; 2017 Jun; 17(1):435. PubMed ID: 28633667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study.
    Franceschi S; Rajkumar T; Vaccarella S; Gajalakshmi V; Sharmila A; Snijders PJ; Muñoz N; Meijer CJ; Herrero R
    Int J Cancer; 2003 Oct; 107(1):127-33. PubMed ID: 12925967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cofactors in human papillomavirus infection and cervical carcinogenesis.
    Yetimalar H; Kasap B; Cukurova K; Yildiz A; Keklik A; Soylu F
    Arch Gynecol Obstet; 2012 Mar; 285(3):805-10. PubMed ID: 21830008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The viral origin of cervical cancer in Rabat, Morocco.
    Chaouki N; Bosch FX; Muñoz N; Meijer CJ; El Gueddari B; El Ghazi A; Deacon J; Castellsagué X; Walboomers JM
    Int J Cancer; 1998 Feb; 75(4):546-54. PubMed ID: 9466654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus infection and invasive cervical cancer in Paraguay.
    Rolón PA; Smith JS; Muñoz N; Klug SJ; Herrero R; Bosch X; Llamosas F; Meijer CJ; Walboomers JM
    Int J Cancer; 2000 Feb; 85(4):486-91. PubMed ID: 10699919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
    Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
    Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer.
    Arnheim Dahlström L; Andersson K; Luostarinen T; Thoresen S; Ögmundsdottír H; Tryggvadottír L; Wiklund F; Skare GB; Eklund C; Sjölin K; Jellum E; Koskela P; Wadell G; Lehtinen M; Dillner J
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2541-50. PubMed ID: 21994401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
    Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
    Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer.
    Dillner J; Lehtinen M; Björge T; Luostarinen T; Youngman L; Jellum E; Koskela P; Gislefoss RE; Hallmans G; Paavonen J; Sapp M; Schiller JT; Hakulinen T; Thoresen S; Hakama M
    J Natl Cancer Inst; 1997 Sep; 89(17):1293-9. PubMed ID: 9293920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus genotype distribution in invasive cervical cancer in Bosnia and Herzegovina.
    Iljazović E; Mena M; Tous S; Alemany L; Omeragić F; Sadiković A; Clavero O; Vergara M; Bosch FX; de Sanjosé S
    Cancer Epidemiol; 2014 Oct; 38(5):504-10. PubMed ID: 25130915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV genotyping from invasive cervical cancer in Chile.
    Roa JC; Garcia P; Gomez J; Fernández W; Gaete F; Espinoza A; Lepetic A; Suarez E
    Int J Gynaecol Obstet; 2009 May; 105(2):150-3. PubMed ID: 19249046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix.
    Sundström K; Eloranta S; Sparén P; Arnheim Dahlström L; Gunnell A; Lindgren A; Palmgren J; Ploner A; Sanjeevi CB; Melbye M; Dillner J; Adami HO; Ylitalo N
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2469-78. PubMed ID: 20671136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and distribution of high risk human papillomavirus (HPV) Types 16 and 18 in Carcinoma of cervix, saliva of patients with oral squamous cell carcinoma and in the general population in Karnataka, India.
    Kulkarni SS; Kulkarni SS; Vastrad PP; Kulkarni BB; Markande AR; Kadakol GS; Hiremath SV; Kaliwal S; Patil BR; Gai PB
    Asian Pac J Cancer Prev; 2011; 12(3):645-8. PubMed ID: 21627358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of high-risk human papillomavirus type 16 and 18 in oral and cervical cancers in population from Gujarat, West India.
    Patel KR; Vajaria BN; Begum R; Desai A; Patel JB; Shah FD; Shukla SN; Patel PS
    J Oral Pathol Med; 2014 Apr; 43(4):293-7. PubMed ID: 24372728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors.
    Hammouda D; Muñoz N; Herrero R; Arslan A; Bouhadef A; Oublil M; Djedeat B; Fontanière B; Snijders P; Meijer C; Franceschi S
    Int J Cancer; 2005 Jan; 113(3):483-9. PubMed ID: 15455386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination.
    Du J; Näsman A; Carlson JW; Ramqvist T; Dalianis T
    Acta Oncol; 2011 Nov; 50(8):1215-9. PubMed ID: 21726177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of human papillomavirus genotypes in archival cervical tissue from women with cervical cancer in urban Sri Lanka.
    Samarawickrema NA; Tabrizi SN; Hewavisenthi J; Leong T; Garland SM
    Int J Gynaecol Obstet; 2011 Nov; 115(2):180-2. PubMed ID: 21872246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.